Sath Shukla's Insider Trades & SAST Disclosures
Sath Shukla's most recent trade in Spero Therapeutics Inc was a trade of 751,407 Common Stock done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sath Shukla.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spero Therapeutics Inc | Sath Shukla | CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 751,407 | 1,892,216 (9%) | 3% | 0 | Common Stock | |
| Spero Therapeutics Inc | Sath Shukla | CEO & President | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 106,408 | 1,736,883 (9%) | 0% | 0.8 | 82,998 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | CEO & President | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 42,786 | 1,843,291 (9%) | 0% | 0.8 | 33,373 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | CEO & President | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 6,139 | 1,886,077 (9%) | 0% | 0.8 | 4,788 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | CEO & President | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 27 Aug 2024 | 2,757 | 1,140,809 (5%) | 0% | 1.4 | 3,722 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | CEO and President | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 02 Aug 2024 | 17,641 | 1,143,566 (5%) | 0% | 1.3 | 23,110 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | CEO and President | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 02 Aug 2024 | 14,800 | 1,161,207 (6%) | 0% | 1.3 | 19,536 | Common Stock |
| Spero Therapeutics Inc | Shukla Sath | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 679,501 | 1,252,001 (6%) | 3% | 0 | Common Stock | |
| Spero Therapeutics Inc | Sath Shukla | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.45 per share. | 01 Feb 2024 | 45,093 | 1,176,007 (6%) | 0% | 1.5 | 65,385 | Common Stock |
| Spero Therapeutics Inc | Shukla Sath | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.37 per share. | 01 Feb 2024 | 30,901 | 1,221,100 (6%) | 0% | 1.4 | 42,334 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 28 Aug 2023 | 4,163 | 572,500 (2%) | 0% | 1.3 | 5,412 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 28 Aug 2023 | 1,854 | 576,663 (2%) | 0% | 1.3 | 2,336 | Common Stock |
| Spero Therapeutics Inc | Sath Shukla | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 266,000 | 578,517 (3%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Sath Shukla | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 265,957 | 322,021 (1%) | 1% | 0 | Common Stock | |
| Spero Therapeutics Inc | Sath Shukla | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 01 Feb 2023 | 9,504 | 312,517 (1%) | 0% | 1.8 | 17,372 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges